華上生醫
| 年度/季度 | 營業現金流 | 投資現金流 | 融資現金流 | 自由現金流 | 淨現金流 | 現金及約當現金餘額 |
|---|
| 2025Q4 | -37,816 | -104,366 | -15,552 | -142,182 | -157,734 | 29,839 |
| 2025Q2 | -49,742 | 113,731 | -31,474 | 63,989 | 32,515 | 187,573 |
| 2024Q4 | -29,818 | -160,025 | 721 | -189,843 | -189,122 | 155,058 |
| 2024Q2 | -47,030 | 26,537 | 185,122 | -20,493 | 164,629 | 344,180 |
| 2023Q4 | -36,196 | -3,430 | 1,806 | -39,626 | -37,820 | 179,551 |
| 2023Q2 | -18,798 | -179,345 | 304,435 | -198,143 | 106,292 | 217,371 |
| 2022Q4 | -51,686 | -132,898 | 203,312 | -184,584 | 18,728 | 111,079 |
| 2022Q2 | -27,930 | 57,493 | 0 | 29,563 | 29,563 | 92,351 |
| 2021Q4 | -34,316 | -28,231 | 0 | -62,547 | -62,547 | 62,788 |
| 2021Q2 | -26,435 | -35,254 | 120,000 | -61,689 | 58,311 | 125,335 |
| 年度/季度 | 營業現金流 | 投資現金流 | 融資現金流 | 自由現金流 | 淨現金流 |
|---|
| 2025Q4 | -87,558 | 9,365 | -47,026 | -78,193 | -125,219 |
| 2025Q2 | -49,742 | 113,731 | -31,474 | 63,989 | 32,515 |
| 2024Q4 | -76,848 | -133,488 | 185,843 | -210,336 | -24,493 |
| 2024Q2 | -47,030 | 26,537 | 185,122 | -20,493 | 164,629 |
| 2023Q4 | -54,994 | -182,775 | 306,241 | -237,769 | 68,472 |
| 2023Q2 | -18,798 | -179,345 | 304,435 | -198,143 | 106,292 |
| 2022Q4 | -79,616 | -75,405 | 203,312 | -155,021 | 48,291 |
| 2022Q2 | -27,930 | 57,493 | 0 | 29,563 | 29,563 |
| 2021Q4 | -60,751 | -63,485 | 120,000 | -124,236 | -4,236 |
| 2021Q2 | -26,435 | -35,254 | 120,000 | -61,689 | 58,311 |
| 年度 | 營業現金流 | 投資現金流 | 融資現金流 | 自由現金流 | 淨現金流 | 現金及約當現金餘額 |
|---|
| 2025 | -87,558 | 9,365 | -47,026 | -78,193 | -125,219 | 29,839 |
| 2024 | -76,848 | -133,488 | 185,843 | -210,336 | -24,493 | 155,058 |
| 2023 | -54,994 | -182,775 | 306,241 | -237,769 | 68,472 | 179,551 |
| 2022 | -79,616 | -75,405 | 203,312 | -155,021 | 48,291 | 111,079 |
| 2021 | -60,751 | -63,485 | 120,000 | -124,236 | -4,236 | 62,788 |